The Enterprise Value as of September 2024 (TTM) for Aadi Bioscience, Inc. (AADI) is 5.58M

According to Aadi Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.58M. This represents a change of -70.38% compared to the average of 18.83M of the last 4 quarters.

Aadi Bioscience, Inc. (AADI) Historical Enterprise Value (quarterly & annually)

How has AADI Enterprise Value performed in the past?

The mean historical Enterprise Value of Aadi Bioscience, Inc. over the last ten years is 88.32M. The current 5.58M Enterprise Value has changed 531.54% with respect to the historical average. Over the past ten years (40 quarters), AADI's Enterprise Value was at its highest in in the September 2020 quarter at 421.67M. The Enterprise Value was at its lowest in in the September 2019 quarter at -10804215.00.

Aadi Bioscience, Inc. (AADI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aadi Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aadi Bioscience, Inc. (AADI) Average Enterprise Value

How has AADI Enterprise Value performed in the past?

The current Enterprise Value of Aadi Bioscience, Inc. (AADI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aadi Bioscience, Inc. (AADI) Enterprise Value vs. Peers

How is AADI’s Enterprise Value compared to its peers?

Aadi Bioscience, Inc.’s Enterprise Value is less than Anebulo Pharmaceuticals, Inc. (49.05M), less than Adagene Inc. (51.29M), less than Acrivon Therapeutics, Inc. Common Stock (221.32M), less than AnaptysBio, Inc. (1.47B), less than Mineralys Therapeutics, Inc. (507.98M), greater than AN2 Therapeutics, Inc. (4.27M), less than Aerovate Therapeutics, Inc. (25.04M), less than Gracell Biotechnologies Inc. (5.46B), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Monte Rosa Therapeutics, Inc. (295.46M), less than Design Therapeutics, Inc. (273.51M), less than Erasca, Inc. (670.76M), less than Rezolute, Inc. (282.08M), less than Ultragenyx Pharmaceutical Inc. (5.95B), less than Crinetics Pharmaceuticals, Inc. (4.07B), less than Arvinas, Inc. (1.58B), less than Revolution Medicines, Inc. (7.20B), less than Kura Oncology, Inc. (1.58B),

Build a custom stock screener for Aadi Bioscience, Inc. (AADI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aadi Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aadi Bioscience, Inc. (AADI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aadi Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.